News search
|
About the CNIC 15 Sep 2026 |
|
About the CNIC 4 Sep 2026 The research demonstrates the benefit of a new gene silencer for treating the disease |
|
Research 4 Aug 2026 Left ventricular hypertrabeculation, an anatomical feature of the heart traditionally linked to higher risk, does not worsen outcomes in patients with dilated cardiomyopathy |
|
About the CNIC 20 Jul 2026 The Foundation recognises the pioneering research into the link between gut microbiota and cardiovascular disease led by David Sancho at the CNIC |
|
Research 7 Jul 2026 Hypertrophic cardiomyopathy is the most common inherited heart disease and the leading cause of sudden cardiac death in young people and athletes |
|
About the CNIC 6 Jul 2026 This tool paves the way for identifying patients who would be suitable candidates for treatment with anticoagulant therapy already available at the clinic |
|
Research 1 Jul 2026 The findings provide new insights for developing strategies aimed at preventing the cardiovascular complications associated with this rare disease |
|
About the CNIC 23 Jun 2026 CARDIOSWITCH aims to uncover how the mechanical activity of heart muscle cells shapes cardiac biology and to develop new regenerative strategies for congenital heart disease |
|
About the CNIC 11 Jun 2026 The meeting forms part of European awareness-raising activities around the European Commission’s new strategy to strengthen prevention, early detection, and management of cardiovascular disease |
|
Research 21 Apr 2026 CNIC scientists identify a biomarker that improves risk prediction in a severe form of heart failure The biomarker MR-proADM improves risk prediction in patients with transthyretin amyloid cardiomyopathy (ATTR-CM) and is associated with greater disease severity, mortality, and heart failure events. |
- 1 of 10
- next ›
















